Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2014-03-21 Remuneration Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2014年限制性股票激励计划实施考核办法
Remuneration Information Classification · 95% confidence The document is titled as an implementation assessment method for a 2014 restricted stock incentive plan by the company 中源协和干细胞生物工程股份公司. It details the purpose, principles, assessment subjects, assessment content, procedures, and application of assessment results related to the company's stock incentive plan. There is no financial data, earnings information, or regulatory filing content. It is a detailed internal governance document related to compensation and incentive plans for directors and senior management. This fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation and incentive plans for executives and directors. The document length is under 5,000 characters, but it is substantive and not merely an announcement. Therefore, the classification is DEF 14A with high confidence.
2014-03-21 Chinese
监事会关于公司限制性股票激励计划之激励对象名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's verification opinion on the list of incentive recipients under a restricted stock incentive plan. It discusses compliance with laws and regulations regarding the stock incentive plan and confirms the eligibility of the incentive recipients. It does not contain financial statements, earnings data, or detailed financial analysis. It is not an announcement of a report publication but a formal opinion related to a stock incentive plan. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and verification statement related to corporate governance and stock incentive plans, not a full report or announcement of voting results or capital changes.
2014-03-21 Chinese
第七届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company 中源协和干细胞生物工程股份公司 regarding approval of a restricted stock incentive plan and related matters. It includes voting results and confirms compliance with relevant laws and regulations. The document is not a full financial report, audit report, or earnings release. It is not a shareholder meeting material or voting result announcement but rather a formal announcement of board/management decisions related to stock incentive plans. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management. The document length is short and focused on board resolutions, not a full report or presentation.
2014-03-21 Chinese
2014年限制性股票激励计划（草案）
Remuneration Information Classification · 95% confidence The document is a detailed plan titled "2014年限制性股票激励计划（草案）" which translates to "2014 Restricted Stock Incentive Plan (Draft)" for 中源协和干细胞生物工程股份公司. It extensively discusses the terms, conditions, eligibility, stock quantities, performance targets, and procedures related to a stock-based incentive plan for company directors, senior management, and key personnel. The document includes legal references, regulatory compliance, and governance related to the stock incentive plan. It is not a financial report, earnings release, or regulatory announcement but a comprehensive management and governance document related to executive compensation and stock incentives. This fits best under Remuneration Information (DEF 14A), which covers detailed compensation and incentive plans for executives and directors.
2014-03-21 Chinese
股权激励计划草案摘要公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a company's 2014 restricted stock incentive plan, including the purpose, scope, number of shares, pricing, vesting conditions, accounting treatment, and procedures related to the stock incentive plan. It includes detailed financial data related to the incentive plan costs and the company's recent financial performance. The document is not a full annual or quarterly report, nor is it an earnings release or a call transcript. It is not a board or management change announcement, nor a voting result or dividend notice. The content focuses on the company's equity incentive plan, which is a capital/financing related update about share issuance to employees and management. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement but a substantive update on financing-related equity incentives.
2014-03-21 Chinese
关于办公地址变更的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the change of the company's office address. It contains no financial data, no mention of reports, no regulatory filings, or other detailed corporate information. It is a general corporate announcement about an administrative change. This type of document does not fit into financial reports, management changes, or other specific categories. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2014-03-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.